(Q45863713)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092807%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Tumor suppressor gene therapy for cancer: from the bench to the clinic (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092807%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092807%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

R D Meng

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092807%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092807%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

published in

Drug Resistance Updates

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092807%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092807%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092807%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

205-210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092807%20AND%20SRC:MED&resulttype=core&format=json

Gene therapy -- promises, problems and prospects

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Cancer gene therapy annual conference 1997: trends and news

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Viral vectors for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

A recombinant E1-deleted canine adenoviral vector capable of transduction and expression of a transgene in human-derived cells and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Antitumoral effect of E1B defective adenoviruses in human malignant cells

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Use of transcription reporters with novel p53 binding sites to target tumour cells expressing endogenous or virally transduced p53 mutants with altered sequence-specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Tumor suppressor genes and human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Suppression of human colorectal carcinoma cell growth by wild-type p53

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Gene therapy for cancer: what have we done and where are we going?

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

In vitro evaluation of a p53-expressing adenovirus as an anti-cancer drug.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

An information-intensive approach to the molecular pharmacology of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

p21 is a universal inhibitor of cyclin kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Inhibition of cyclin-dependent kinases by p21

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Tumor suppression and inhibition of aneuploid cell accumulation in human brain tumor cells by ectopic overexpression of the cyclin-dependent kinase inhibitor p27KIP1.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Role of the p16 tumor suppressor gene in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

The retinoblastoma protein and cell cycle control

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Role of the retinoblastoma protein in the pathogenesis of human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Role of p53 in apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

BRCA1 physically associates with p53 and stimulates its transcriptional activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

In vitro growth suppression by adenoviral transduction of p21 and p16 in squamous cell carcinoma of the head and neck: a research model for combination gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

CTS1: a p53-derived chimeric tumor suppressor gene with enhanced in vitro apoptotic properties

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

No stranger to controversy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980041-1

7 January 2021

10.1016/S1368-7646(98)80041-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092807%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference